Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis
Clinical trial NCT02174419 · COMPLETED
Trial details
- NCT number
- NCT02174419
- Sponsor
- Trevi Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2016-08-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.